Phase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast Cancer
Completed · Phase 3
Conditions studied: Breast Cancer
In brief
This Phase 3 clinical study compares the efficacy and safety of elacestrant to the standard of care (SoC) options of fulvestrant or an aromatase inhibitor (AI) in women and men with breast cancer whose disease has advanced on at least one endocrine therapy including a CDK4/6 inhibitor in combination with fulvestrant or an aromatase inhibitor (AI).
Key facts
- Study ID
- NCT03778931
- Run by
- Stemline Therapeutics, Inc.
- People needed
- 478
- Starts
- 2019-05-10
- Expected to finish
- 2024-08-22
- Last updated by the study team
- 2025-09-15
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- St Bernard's Cancer Care — Jonesboro, Arkansas, United States
- St. Jude Heritage Healthcare — Fullerton, California, United States
- Adventist Health Glendale — Glendale, California, United States
- Moores Cancer Center at UC San Diego Health — La Jolla, California, United States
- Keck Hospital of USC-Norris Healthcare (HC3), Investigational Drug Service (IDS) — Los Angeles, California, United States
- Keck Medical Center of USC — Los Angeles, California, United States
- USC IDS Pharmacy — Los Angeles, California, United States
- UCLA Hematology/Oncology — Los Angeles, California, United States
- UCLA West Medical Pharmacy 159 — Los Angeles, California, United States
- TMPN Cancer Care — Redondo Beach, California, United States
- UC Davis Medical Center, Investigational Drug Service — Sacramento, California, United States
- UCSF Medical Center — San Francisco, California, United States
- Ridley-Tree Cancer Center — Santa Barbara, California, United States
- Anschutz Cancer Center Pavilion — Aurora, Colorado, United States
- US Oncology - Rocky Mountain Cancer Centers - Midtown — Denver, Colorado, United States
- Poudre Valley Health Care, Inc. d/b/a Poudre Valley Health System — Fort Collins, Colorado, United States
- UCHealth Cancer Center — Fort Collins, Colorado, United States
- Yale Cancer Center — New Haven, Connecticut, United States
- MedStar Washington Hospital Center — Washington D.C., District of Columbia, United States
- Orlando Health Cancer Institute — Orlando, Florida, United States
- Moffitt Cancer Center — Tampa, Florida, United States
- Piedmont Cancer Institute, P.C. - Oncology — Atlanta, Georgia, United States
- Suburban Hematology-Oncology Associates — Lawrenceville, Georgia, United States
- Northwest Georgia Oncology Centers — Marietta, Georgia, United States
- The University of Arizona Cancer Center — Tucson, Arizona, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.